{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:08:03Z","timestamp":1785838083024,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:00:00Z","timestamp":1498176000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11-00842"],"award-info":[{"award-number":["PI11-00842"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Enhancement and Enrichment of life"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00431-017-2950-8","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:13:20Z","timestamp":1498184000000},"page":"1075-1081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Newborn screening for Fabry disease in the north-west of Spain"],"prefix":"10.1007","volume":"176","author":[{"given":"Cristobal","family":"Colon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saida","family":"Ortolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Melcon-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose V.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalla E.","family":"Lopez-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Couce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Fern\u00e1ndez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"key":"2950_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2014.225771","volume":"61","author":"MH Gelb","year":"2015","unstructured":"Gelb MH, Scott CR, Turecek F (2015) Newborn screening for lysosomal storage diseases. Clin Chem 61:335\u2013346","journal-title":"Clin Chem"},{"key":"2950_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1872214808666140115111350","volume":"8","author":"S Ortolano","year":"2015","unstructured":"Ortolano S, Vieitez I, Navarro C, Spuch C (2015) Treatment of lysosomal storage disease: recent patents and future strategies. Recent Pat Endocr Metab Immune Drug Discovery 8:9\u201325","journal-title":"Recent Pat Endocr Metab Immune Drug Discovery"},{"key":"2950_CR3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.semperi.2015.03.005","volume":"39","author":"D Matern","year":"2015","unstructured":"Matern D, Gavrilov D, Oglesbee D, Raymond K, Rinaldo P, Tortorelli S (2015) Newborn screening for lysosomal storage disorders. Seminar Perinatology 39:206\u2013216","journal-title":"Seminar Perinatology"},{"key":"2950_CR4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10545-011-9435-0","volume":"35","author":"LF Ross","year":"2012","unstructured":"Ross LF (2012) Newborn screening for lysosomal storage diseases: an ethical and policy analysis. Journal of Inherited Metabolic Diseases 35:627\u2013634","journal-title":"Journal of Inherited Metabolic Diseases"},{"key":"2950_CR5","first-page":"69","volume":"7","author":"M Alfadhel","year":"2011","unstructured":"Alfadhel M, Sirrs S (2011) Enzyme replacement therapy for Fabry disease: some answers but more questions. J Ther Clin Risk Manag 7:69\u201382","journal-title":"J Ther Clin Risk Manag"},{"key":"2950_CR6","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.2147\/DDDT.S80928","volume":"9","author":"L Golan","year":"2015","unstructured":"Golan L, Goker-Alpan O, Holida M, Kantola I, Klopotowski M, Kuusisto J et al (2015) Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease. J Drug Des Dev Ther 9:3435\u20133444","journal-title":"J Drug Des Dev Ther"},{"key":"2950_CR7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A et al (2003) Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype. Kidney Int 64:801\u2013807","journal-title":"Kidney Int"},{"key":"2950_CR8","first-page":"101","volume":"8","author":"W Terryn","year":"2013","unstructured":"Terryn W, Vanholder R, Hemelsoet D, Leroy BP, Van Biesen W, De Schoenmakere G et al (2013) Questioning the pathogenic role of the GLA p.Ala143Thr \u201cmutation\u201d in Fabry disease: implications for screening studies and ERT. J Inherit Metab Dis 8:101\u2013108","journal-title":"J Inherit Metab Dis"},{"key":"2950_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","volume":"166","author":"PV Hopkins","year":"2015","unstructured":"Hopkins PV, Campbell C, Klug T, Rogers S, Raburn-Miller J, Kiesling J (2015) Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri. J Pediatr 166:172\u2013177","journal-title":"J Pediatr"},{"key":"2950_CR10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/mt.2015.62","volume":"23","author":"G Parenti","year":"2015","unstructured":"Parenti G, Andria G, Valenzano KJ (2015) Pharmacological chaperone therapy: preclinical development, clinical translation and prospects for the treatment of lysosomal storage disorders. Mol Ther 23:1138\u20131148","journal-title":"Mol Ther"},{"key":"2950_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","volume":"308","author":"NA Chamoles","year":"2001","unstructured":"Chamoles NA, Blanco M, Gaggioli D (2001) Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta 308:195\u2013196","journal-title":"Clin Chim Acta"},{"key":"2950_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","volume":"2","author":"J Shabbeer","year":"2006","unstructured":"Shabbeer J, Yasuda M, Benson SD, Desnick RJ (2006) Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations. Human Genomics 2:297\u2013309","journal-title":"Human Genomics"},{"key":"2950_CR13","unstructured":"Human Gene Mutation Database \nhttp:\/\/hgmd.cf.ac.uk\/ac\/index.php\n\n, 09\/01\/2017"},{"key":"2950_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. J Am Med Assoc 281:249\u2013254","journal-title":"J Am Med Assoc"},{"key":"2950_CR15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/jhg.2013.48","volume":"58","author":"T Inoue","year":"2013","unstructured":"Inoue T, Hattori K, Ihara K, Ishii A, Nakamura K, Hirose S (2013) Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. J Hum Genet 58:548\u2013552","journal-title":"J Hum Genet"},{"key":"2950_CR16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","volume":"2","author":"HY Lin","year":"2009","unstructured":"Lin HY, Chong KW, Hsu JH, Yu HC, Shih CC, Huang CH et al (2009) High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet 2:450\u2013456","journal-title":"Circ Cardiovasc Genet"},{"key":"2950_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H et al (2006) High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79:31\u201340","journal-title":"Am J Hum Genet"},{"key":"2950_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","volume":"51","author":"L Tol van der","year":"2014","unstructured":"van der Tol L, Smid BE, Poorthuis BJ, Biegstraaten M, Deprez RH, Linthorst GE et al (2014) Systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet 51:1\u20139","journal-title":"J Med Genet"},{"issue":"12","key":"2950_CR19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/gim.2016.55","volume":"18","author":"R Schiffmann","year":"2016","unstructured":"Schiffmann R, Fuller M, Clarke LA, Aerts JM (2016) Is it Fabry disease? Genet Med 18(12):1181\u20131185","journal-title":"Genet Med"},{"key":"2950_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1096-7192(03)00136-7","volume":"80","author":"R Froissart","year":"2003","unstructured":"Froissart R, Guffon N, Vanier MT, Desnick RJ, Maire I (2003) Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma. Mol Genet Metab 80:307\u2013314","journal-title":"Mol Genet Metab"},{"key":"2950_CR21","unstructured":"NCBI-SNPs Database- (\nhttp:\/\/ncbi.nlm.nih.gov\/snp\n\n, 09\/01\/17)"},{"key":"2950_CR22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gene.2014.08.004","volume":"549","author":"DA Zeevi","year":"2014","unstructured":"Zeevi DA, Hakam-Spector E, Herskovitz Y, Beeri R, Elstein D, Altarescu G (2014) An intronic haplotype in alpha galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke. Gene 549:275\u2013279","journal-title":"Gene"},{"key":"2950_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12863-015-0267-z","volume":"16","author":"J Gervas-Arruga","year":"2015","unstructured":"Gervas-Arruga J, Cebolla JJ, Irun P, Perez-Lopez J, Plaza L, Roche JC et al (2015) Increased glycolipid storage produced by the inheritance of a complex intronic haplotype in the alpha-galactosidase A gene (GLA). BMC Genomics 16:109\u2013121","journal-title":"BMC Genomics"},{"key":"2950_CR24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","volume":"163","author":"CR Scott","year":"2013","unstructured":"Scott CR, Elliott S, Buroker N, Thomas LI, Keutzer J, Glass M et al (2013) Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry. J Pediatr 163:498\u2013503","journal-title":"J Pediatr"},{"key":"2950_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","volume":"29","author":"M Gelb","year":"2006","unstructured":"Gelb M, Turecek F, Scott CR, Chamoles NA (2006) Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 29:397\u2013404","journal-title":"J Inherit Metab Dis"},{"key":"2950_CR26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10897-015-9879-8","volume":"25","author":"EC Lisi","year":"2016","unstructured":"Lisi EC, McCandless SE (2016) Newborn screening for lysosomal storage disorders: views of genetic healthcare providers. J Genet Couns 25:373\u2013384","journal-title":"J Genet Couns"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-017-2950-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-017-2950-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-017-2950-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T05:37:06Z","timestamp":1500010626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-017-2950-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1007\/s00431-017-2950-8","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,23]]}}}